Новини фондового ринку
Останні фінансові новини · Оновлено Тра 22, 2026
Головний науковий співробітник Immunome скоротив свою частку. Запланована подача до FDA розповість вам більше
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More
The panel largely agrees that Immunome's current valuation is frothy, with a market cap of $2.4 billion on $6.94 million …
5,6% дивідендів: чи є Verizon чудовою дивідендною акцією для купівлі?
Yielding 5.6%, Is Verizon an Excellent Dividend Stock to Buy?
The panel consensus is that Verizon's (VZ) 5.6% yield is not sustainable given its high capex requirements, stagnant top-line growth, …
Волатильність фондового ринку зростає: 1 чудовий акціонер, який ви можете купити за вигідною ціною сьогодні
Stock Market Volatility is Increasing: 1 Spectacular Stock You Can Buy at a Bargain Price Today
The panel consensus is that the article is promotional and lacks concrete valuation metrics to support its 'bargain' claim on …
Головний медичний директор Maze Therapeutics продав 100% своїх прямих володінь. Ось що це означає для інвесторів.
Maze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.
The panel's discussion centered around the liquidation of 100% of MAZE Therapeutics' CMO's direct holdings, with a focus on the …
3 акції з високою прибутковістю для купівлі з $1,000 та утримання назавжди
3 High-Yield Stocks to Buy With $1,000 and Hold Forever
The panel consensus is bearish on the 'hold forever' strategy for BNS, O, and EPD, citing macro-sensitivity, tax headwinds, and …
Аналіз акцій UnitedHealth: Генераційна можливість купівлі чи падаючий ніж, якого слід уникати?
UnitedHealth Stock Analysis: Generational Buying Opportunity or a Falling Knife to Avoid?
The panel consensus is that UNH's current valuation is uncertain due to elevated medical loss ratios, Medicare Advantage reimbursement cuts, …
1 Секретна Підцінена Акція, Яку Можна Купити, Про Яку Ніхто Не Говорить
1 Secret Undervalued Stock You Can Buy That Nobody is Talking About
The panel consensus is that the article is a marketing ploy rather than a genuine investment opportunity. The unnamed 'indispensable …
Аналіз акцій CoreWeave: Купувати чи продавати ці акції AI, підтримані Nvidia?
CoreWeave Stock Analysis: Buy or Sell This Nvidia-Backed AI Stock?
The panel consensus is that CoreWeave (CRWV) faces significant risks, with key concerns being high leverage, vulnerability to Nvidia price …
Занепад суду присяжних
The Demise Of Trial By Jury
The panel discusses the potential impact of the UK's proposed 'swift courts' on the legal and insurance sectors. While some …
Тегеранська платна дорога для проливу Гормуз ділить країни на 3 категорії
Tehran's Toll Booth For Hormuz Strait Divides Countries Into 3 Categories
The panel agrees that Iran's 'Tehran Toll Booth' initiative will increase transit costs and risks, potentially leading to a permanent …
Менше половини працівників охорони здоров'я отримали оновлену вакцину проти COVID-19: CDC
Less Than Half Of Health Care Workers Received An Updated COVID-19 Vaccine: CDC
The panel agrees that COVID-19 vaccination rates among healthcare workers remain low (40.2%) despite their frontline exposure, with mandates being …
Deutsche Bank бачить ризики витрат і попиту, скорочує General Mills (GIS)
Deutsche Bank Sees Cost and Demand Risks, Trims General Mills (GIS)
Analysts express bearish sentiments towards GIS due to macro headwinds, margin compression, and potential dividend risk. However, there's disagreement on …